Co-Founder and Director at Improving Global Health, Inc. and Scientific Founder at Stealth BioTherapeutics.
Hazel Szeto, PhD, MD, is a research scientist, inventor, and entrepreneur in drug development. She received her MD and PhD in Pharmacology from Cornell and served on the faculty for 37 years. In 2016, Dr. Szeto left to direct research for Social Profit Network, a public charity supporting research to promote healthy aging and reduce age-associated disabilities. Dr. Szeto has developed the first class of compounds that selectively target mitochondria to enhance ATP production, repair mitochondria, regenerate tissues, and restore organ function. These compounds are now in clinical development sponsored by Stealth Biotherapeutics, a company founded by Dr. Szeto in 2006. Dr. Szeto’s research has resulted in over 200 peer-reviewed publications and more than 60 patents.
Visit website: http://www.metabesity2020.com/hazel-szeto.html
See also: Stealth BioTherapeutics - Biopharmaceutical company focused on the discovery and commercialization of novel therapies..
Hazel Szeto is also referenced in the following:
11-Oct-2021 to 14-Oct-2021
The Kitalys institute virtual conference targeting key questions that will impact the future of aging and extending healthspan
Mitochondria, Aging, and Health
Speakers are Douglas Wallace, Francesca Fieni, Hazel Szeto and Michael Zemel
Hazel Szeto News
Folds in mitochondria membrane are lost as we age - reducing production of ATP
I Spy Physiology - 12-May-2021
Antioxidant treatment reversed mitochondrial ageing via cardiolipin in miceRead more...